Nizhny Novgorod rolls out free health screenings to detect early ageing signs
Nizhny Novgorod rolls out free health screenings to detect early ageing signs
Nizhny Novgorod rolls out free health screenings to detect early ageing signs
Residents of Nizhny Novgorod now have access to free health equity screenings aimed at detecting early signs of ageing. The programme, open to anyone aged 18 or older, is available at local health insurance centres across the city. Participants will receive personalised advice on nutrition and exercise to support long-term health.
The screenings focus on identifying hidden health issues before symptoms appear. Doctors will assess metabolic function, check for hormonal imbalances, and evaluate vascular and cognitive health. Even subtle problems, such as low-grade inflammation or early cognitive decline, can be spotted through the tests.
No official figures have been released on how many people have taken part since the initiative launched. However, the service remains free and accessible to all eligible residents.
After the assessment, each participant will receive tailored recommendations. These will cover diet, physical activity, and lifestyle adjustments to help maintain an active and healthy life.
The programme aims to catch potential health concerns at an early stage. By offering free screenings and personalised guidance, local authorities hope to improve long-term health outcomes for residents. The initiative is ongoing, with no set end date announced.
Garlic, Vitamin C, and Chlorophyll Team Up for Heart Health Breakthrough
Could a simple blend of garlic, vitamin C, and chlorophyll be the key to a healthier heart? New findings reveal surprising benefits for blood pressure and beyond.
Chuck Norris, 86, hospitalized after medical emergency in Hawaii
From Walker, Texas Ranger to recent films, Norris never slowed down—until now. Fans worldwide await news after his sudden hospitalization.
Blood Test Breakthrough Could Detect Hidden Artery Disease Years Earlier
A simple blood test could soon reveal invisible plaque buildup—long before it triggers a deadly event. Machine learning cracked the code in 45,000 patients' data.
Eli Lilly's retatrutide shows groundbreaking results in Type 2 diabetes trial
A triple-hormone drug could redefine diabetes care. Early data shows retatrutide outperforms competitors—but will regulators agree?